Cost of asthma in children: A nationwide, population-based, cost-of-illness study

Pediatric Allergy and Immunology

Volumn 28, Issue 7, 2017, Pages 683-691

  Ferreira de Magalhães, Manuel ^a,b   Amaral, Rita ^b   Pereira, Ana M ^b,c   Sá Sousa, Ana ^b   Azevedo, Inês ^a,b   Azevedo, Luís F ^b   Fonseca, João A ^b,c  

^a Universidade do Porto   (Portugal)

^b University of Porto   (Portugal)

^c Institute CUF   (Portugal)

Author keywords

burden; economics; health services research; paediatrics; pulmonary medicine

Indexed keywords

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CHILD HOSPITALIZATION; COST OF ILLNESS; DISEASE CONTROL; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PORTUGUESE (CITIZEN); PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; ECONOMICS; HEALTH SURVEY; INFANT; PORTUGAL; PREVALENCE;

ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; FEMALE; HEALTH SURVEYS; HUMANS; INFANT; MALE; PORTUGAL; PREVALENCE;

EID: 85033500423     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12772     Document Type: Article

References (29)

1. Williams I, McIver S, Moore D, et al. The use of economic evaluations in NHS decision-making: a review and empirical investigation. Health Technol Assess. 2008;12:1-175.
2. Larg A, Moss JR. Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics. 2011;29:653-671.
3. Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20:327-337.
4. Goodman CS. HTA 101:Introduction to Health Technology Assessment. Bethesda, M.D.: National Library of Medicine (US); 2014.
5. Blasco Bravo AJ, Pérez-Yarza EG, De Mercado PLY, et al. Coste del asma en pediatría en España: un modelo de evaluación de costes basado en la prevalencia. An Pediatr. 2011;74:145-153.
6. Druss BG, Marcus SC, Olfson M, et al. The most expensive medical conditions in America. Health Aff. 2002;21:105-111.
7. Barnett SBL, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol. 2011;127:145-152.
8. Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009;9:1-16.
9. Ferreira-Magalhaes M, Sa-Sousa A, Morais-Almeida M, et al. Asthma-like symptoms, diagnostic tests, and asthma medication use in children and adolescents: a population-based nationwide survey. J Asthma. 2016;53:269-276.
10. Ferreira-Magalhães M, Pereira AM, Sá-Sousa A, et al. Asthma control in children is associated with nasal symptoms, obesity, and health insurance: a nationwide survey. Pediatr Allergy Immunol. 2015;26:466-473.
11. Serviço Nacional de Saúde—Relatório e Contas 2010. Administração Central dos Serviços de Saúde. Lisboa 2010.
12. Portaria n.º 132/2009 de 30 de Janeiro do Ministério da Saúde. Diário da República: 1ª série, n.º 21. http://www.dre.pt. Accessed January 21, 2015.
13. Infomed. http://app7.infarmed.pt/infomed. Accessed January 21, 2015.
14. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2016. http://www.ginasthma.org. Accessed September 13, 2016.
15. Diário daPortaria n.º 132/ 2009 de 30 de Janeiro do Ministério da Saúde. República: 1ª série, n.º 21. http://www.dre.pt. Accessed January 21, 2015.
16. Infomed. http://app7.infarmed.pt/infomed. Accessed January 21, 2015.
17. Portaria n.º 511/2009 de 14 de Maio do Ministério das Finaças e da Administração Pública e do Trabalho e da Solidariedade Social. Diário da República: 1ª série, n.º 93. http://www.dre.pt. Accessed January 21, 2015.
18. Drummond MF, Sculper MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes, 3rd edn. New York, NY: Oxford University Press; 2005.
19. Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health. 2002;23:377-401.
20. Segel JE. Cost-of-Illness Studies—A Primer. RTI-UNC Center of Excellence in Health Promotion Economics. North Carolina, USA: RTI International; 2006.
21. Wang LY, Zhong Y, Wheeler L. Direct and indirect costs of asthma in school-age children. Prev Chronic Dis. 2005;2:1-10.
22. Beyhun NE, Soyer ÖU, Kuyucu S, et al. A multi-center survey of childhood asthma in Turkey—I: the cost and its determinants. Pediatr Allergy Immunol. 2009;20:72-80.
23. Herjavecz I, Nagy GB, Gyurkovits K, et al. Cost, morbidity, and control of asthma in Hungary: the Hunair Study. J Asthma. 2003;40:673-681.
24. Ferreira-Magalhães M, Sá-Sousa A, Morais-Almeida M, et al. High prevalence of hospitalisation for asthma in a population-based paediatric sample. Arch Dis Child. 2015;100:507-508.
25. Noyes K, Bajorska A, Fisher S, et al. Cost-effectiveness of the school-based asthma therapy (SBAT) program. Pediatrics. 2013;131:e709-e717.
26. Karnick P, Margellos-Anast H, Seals G, et al. The pediatric asthma intervention: a comprehensive cost-effective approach to asthma management in a disadvantaged inner-city community. J Asthma. 2007;44:39-44.
27. Briggs AH, Gray AM. Handling uncertainty in economic evaluations of healthcare interventions. BMJ. 1999;319:635-638.
28. Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS)-explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Heal. 2013;16:231-250.
29. Brookman A, Davies G. A validation of the health and social costs of asthma using questionnaire data. IJPDS. 2017;1:164.